{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:01:16Z","timestamp":1785542476694,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1118-8","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T03:23:40Z","timestamp":1541474620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Renal-limited AL amyloidosis \u2013 a diagnostic and management dilemma"],"prefix":"10.1186","volume":"19","author":[{"given":"Kar Wah","family":"Fuah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3623-0484","authenticated-orcid":false,"given":"Christopher Thiam Seong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"key":"1118_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2141.2001.02999.x","volume":"114","author":"RA Kyle","year":"2001","unstructured":"Kyle RA. Amyloidosis: a convoluted story. Br J Haematol. 2001;114:529.","journal-title":"Br J Haematol"},{"key":"1118_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1586\/17474086.2014.858594","volume":"7","author":"G Merlini","year":"2014","unstructured":"Merlini G, Comenzo RL, Seldin DC, et al. Immunoglobulin light chain amyloidosis. Expert Rev Hematol. 2014;7:143.","journal-title":"Expert Rev Hematol"},{"key":"1118_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJM197402282900902","volume":"290","author":"T Isobe","year":"1974","unstructured":"Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med. 1974;290:473\u20137.","journal-title":"N Engl J Med"},{"key":"1118_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jaad.2005.12.031","volume":"54","author":"Y Fujita","year":"2006","unstructured":"Fujita Y, Tsuji-Abe Y, Sato-Matsumura KC, et al. Nail dystrophy and blisters as sole manifestations in myeloma-associated amyloidosis. J Am Acad Dermatol. 2006;54:712.","journal-title":"J Am Acad Dermatol"},{"key":"1118_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/13506120308995256","volume":"10","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Lacy MQ, Dispenzieri A. Localized AL amyloidosis of the colon: an unrecognized entity. Amyloid. 2003;10:36.","journal-title":"Amyloid"},{"key":"1118_CR6","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.4065\/75.12.1264","volume":"75","author":"O Tirzaman","year":"2000","unstructured":"Tirzaman O, Wahner-Roedler DL, Malek RS, et al. Primary localized amyloidosis of the urinary bladder: a case series of 31 patients. Mayo Clin Proc. 2000;75:1264.","journal-title":"Mayo Clin Proc"},{"key":"1118_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0165-5876(96)01330-4","volume":"36","author":"S Dom\u00ednguez","year":"1996","unstructured":"Dom\u00ednguez S, Wienberg P, Clar\u00f3s P, et al. Primary localized nasopharyngeal amyloidosis. A case report. Int J Pediatr Otorhinolaryngol. 1996;36:61.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1118_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0889-8588(18)30347-2","volume":"6","author":"J Buxbaum","year":"1992","unstructured":"Buxbaum J. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol Oncol Clin North Am. 1992;6:323\u201346.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1118_CR9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJM198006053022305","volume":"302","author":"GG Glenner","year":"1980","unstructured":"Glenner GG. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med. 1980;302:1283.","journal-title":"N Engl J Med"},{"key":"1118_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5414\/CN107151","volume":"79","author":"N Kurita","year":"2013","unstructured":"Kurita N, Kotera N, Ishimoto Y, et al. AA amyloid nephropathy with predominant vascular deposition in Crohn's disease. Clin Nephrol. 2013;79:229.","journal-title":"Clin Nephrol"},{"key":"1118_CR11","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/labinvest.3700161","volume":"84","author":"J Keeling","year":"2004","unstructured":"Keeling J, Teng J, Herrera GA. AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells. Lab Investig. 2004;84:1322.","journal-title":"Lab Investig"},{"key":"1118_CR12","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","volume":"114","author":"JA Vrana","year":"2009","unstructured":"Vrana JA, Gamez JD, Madden BJ, et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114:4957.","journal-title":"Blood"},{"key":"1118_CR13","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.2215\/CJN.02890310","volume":"5","author":"S Sethi","year":"2010","unstructured":"Sethi S, Theis JD, Leung N, et al. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol. 2010;5:2180.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1118_CR14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0002-9343(81)90326-0","volume":"71","author":"RA Kyle","year":"1981","unstructured":"Kyle RA, Robinson RA, Katzmann JA. The clinical aspects of biclonal gammopathies. Review of 57 cases. Am J Med. 1981;71:999.","journal-title":"Am J Med"},{"key":"1118_CR15","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1182\/blood-2010-04-277566","volume":"116","author":"G Bianchi","year":"2010","unstructured":"Bianchi G, Kyle RA, Colby CL, et al. Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications. Blood. 2010;116:2019.","journal-title":"Blood"},{"key":"1118_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564.","journal-title":"N Engl J Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1118-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T19:18:11Z","timestamp":1572981491000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1118-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1118-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Non applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"307"}}